What does Epics Therapeutics do?
EPICS THERAPEUTICS specializes in developing innovative therapies for treating neurodegenerative diseases. The company focuses on harnessing advanced technologies and scientific research to create effective solutions for patients. Its mission is to improve the quality of life for individuals affected by these challenging conditions.
- Sectors
- Forestry companies
- Activities
- Signals
-
Reporting lossesReporting losses € -5.79M
The company reported a loss in the latest financial year.
Strong equityStrong equity € 9.11MStrong equity provides a buffer against setbacks.
Low riskLow risk 62.0%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 5.77A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 618KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 926KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 15.5%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
4.23M
|
€
4.04M
|
€
3.36M
|
€
4.59M
|
|
|
€
926K
|
€
836K
|
€
394K
|
€
1.65M
|
|
|
€
-5.79M
|
€
-4.84M
|
€
-6.26M
|
€
-5.40M
|
|
|
€
9.11M
|
€
7.91M
|
€
7.75M
|
€
14.00M
|
|
|
61.97%
|
57.2%
|
83.14%
|
87.45%
|
|
|
€
5.59M
|
€
5.92M
|
€
1.57M
|
€
2.01M
|
|
|
€
10.20M
|
€
8.78M
|
€
5.66M
|
€
12.18M
|
|
|
33.30
|
31.70
|
31.70
|
31.80
|
Publications 20
All publications- Capital, Actions - Demissions, Nominations 16/07/2024
- Demissions, Nominations 22/05/2023
- Demissions, Nominations 30/12/2022
- Statuts (Traduction, Coordination, Autres Modifications, ) - Demissions, Nominations 03/10/2022
- Capital, Actions 28/04/2022
Frequently asked questions
Answers to the most common questions about Epics Therapeutics, based on official government data and the filed annual accounts.
What is the VAT number of Epics Therapeutics?
The VAT number of Epics Therapeutics is BE0690.759.071.
How many employees work at Epics Therapeutics?
In 2025, Epics Therapeutics employed 33.30 full-time equivalents (FTE).
When was Epics Therapeutics established?
Epics Therapeutics was founded in 20-02-2018.
What is the official address of Epics Therapeutics?
The official address of Epics Therapeutics is Rue Adrienne Bolland 47 Charleroi 6041.
What is the legal form of Epics Therapeutics?
The juridical form of Epics Therapeutics is Public limited company (NV/SA).
What is the annual revenue of Epics Therapeutics?
The 2025 accounts of Epics Therapeutics do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Epics Therapeutics do?
EPICS THERAPEUTICS specializes in developing innovative therapies for treating neurodegenerative diseases. The company focuses on harnessing advanced technologies and scientific research to create effective solutions for patients. Its mission is to improve the quality of life for individuals affected by these challenging conditions.
Is Epics Therapeutics a reliable company?
Epics Therapeutics is a registered Rechtspersoon with company number 0690.759.071 and can be verified through the official CBE database.
What is the credit limit of Epics Therapeutics?
The estimated credit limit of Epics Therapeutics is €1,346,793.
Is Epics Therapeutics still active?
Epics Therapeutics currently has the status "Normal situation" and is active.